Diabetes News and Research

Latest Diabetes News and Research

Study on role of recorded ODLs in improving clinical care for low-weight babies: RWJF awards $480,000 grant

Researchers at Charles Drew University of Medicine and Science and UC Irvine will monitor the day-to-day health of low-birth-weight babies and their parents as part of a comprehensive initiative designed to combat chronic illnesses associated with low-weight births.

4 Mar 2010

Belatacept drug can prevent graft rejection in kidney transplant recipients

The experimental drug belatacept can prevent graft rejection in kidney transplant recipients while better preserving kidney function when compared with standard immunosuppressive drugs, data from two international phase III clinical trials show.

4 Mar 2010

Study suggests vitamin D supplements may decrease insulin resistance, fight depression

A daily dose of vitamin D may just be what Chicagoans need to get through the long winter, according to researchers at Loyola University Chicago Marcella Niehoff School of Nursing (MNSON). This nutrient lifts mood during cold weather months when days are short and more time is spent indoors.

4 Mar 2010

Study indicates ocular shingles may increase stroke risk

Having a shingles infection that affects the eyes may increase the risk of stroke, according to new research published in the March 3, 2010, online issue of Neurology®, the medical journal of the American Academy of Neurology.

4 Mar 2010

HHS Secretary asks Olympic athletes to combat the challenge of childhood obesity

Today the U.S. Department of Health and Human Services released the first in a series of web videos and public service announcements to promote First Lady Michelle Obama’s national initiative, Let’s Move, to solve childhood obesity within a generation. Childhood obesity and excess weight threatens the healthy future of one third of American children.

3 Mar 2010

CPEX Pharmaceuticals' fourth-quarter 2009 revenues up 23%

CPEX Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2009. For the quarter CPEX reported revenues of $5.2 million and a net loss of $498,000. For the year CPEX reported revenues of $18.7 million and a net loss of $3.0 million.

3 Mar 2010

VUCCC files for patent protection: New treatment regimen for Type 1 insulin-dependent diabetes

VUCCC P/L is pleased to announce that it has filed for patent protection of its ground breaking new treatment regimen for Type 1 'insulin-dependent' diabetes, through the European Patent Office.

3 Mar 2010

Positive clinical trial results of EndoBarrier Gastrointestinal Liner device announced

GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, today announced initial, positive results from a clinical trial evaluating 12 months of treatment with the EndoBarrier™ Gastrointestinal Liner.

3 Mar 2010

"Stem cells in drug discovery and development" workshop to be held during toxicology annual meeting

Cellular Dynamics International (CDI) and Hoffmann-La Roche Inc. (Roche) today announced a workshop to be held during the Society of Toxicology Annual Meeting in Salt Lake City, UT, on March 7 - 11.

3 Mar 2010

Merck’s MF/F Phase III study data presented at AAAAI annual meeting

Data from two Phase III studies of Merck’s investigational fixed-dose combinations of mometasone furoate and formoterol fumarate (MF/F) were presented by researchers today in two poster presentations at the American Academy of Allergy, Asthma & Immunology (AAAAI) annual meeting.

3 Mar 2010

Merck announces updated late-stage pipeline following its recent merger with Schering-Plough

Merck & Co., Inc. today announced its updated, newly integrated, late-stage pipeline following its recent merger with Schering-Plough. The new pipeline features a broad and diversified portfolio of investigational medicines and vaccines, including more than 20 candidates in Phase III or under regulatory review, and more than 20 candidates in Phase II of development.

3 Mar 2010

Diabetics at risk: Nova Scotia limits pharmacare coverage of blood glucose test strips

The Nova Scotia government's decision to limit Pharmacare coverage of blood glucose test strips for some diabetes patients places a significant financial and health burden on these Nova Scotians and violates the fundamental principle that patients and their healthcare professionals should be able to determine how to manage treatment.

3 Mar 2010

Instacare announces filing of patent application for MD@Hand technologies

Instacare Corp., a leading provider of prescription drugs, home testing products for the chronically ill, a leading fulfillment provider of direct to patient diabetes programs, and a leading developer of revolutionary cell phone centric e-health products and technologies, today announced that on Friday, February 26, 2010, the Company filed a Provisional Patent Application to secure its MD@Hand technologies.

3 Mar 2010

Common diabetes therapies may increase cancer risk, but more research needed

The benefits of using insulin to treat diabetes far outweigh the risks, but a review just published online by IJCP, the International Journal of Clinical Practice, suggests that commonly used diabetes therapies may differ from each other when it comes to their influence on cancer risk.

3 Mar 2010

Astellas commences unsolicited tender offer to acquire common shares of OSI for $52.00 per share

OSI Pharmaceuticals, Inc. today confirmed that Astellas Pharma Inc. has commenced an unsolicited tender offer to acquire all outstanding common shares of OSI for $52.00 per share in cash.

3 Mar 2010

Junk food consumption on the rise among U. S. children

Children in the United States are snacking more than ever before on salty chips, candy and other junk food, according to a new University of North Carolina at Chapel Hill study.

3 Mar 2010

Nemours: New efforts to reduce prevalence of overweight and obesity among Delaware's children

The prevalence of overweight and obesity among Delaware children, ages 2-17, shows a flattening of the trajectory – no change- between 2006 and 2008. Because overweight and obesity rates had previously been climbing rapidly, the leveling-off is cause for optimism reports Nemours in the March 2010 edition of Health Affairs, a peer-reviewed publication and the country's most respected health policy journal.

3 Mar 2010

Lotus Pharmaceuticals adds five new prescription drugs to its products

Lotus Pharmaceuticals, Inc., a growing developer and producer of prescription drugs and licensed national seller of pharmaceutical products in the People's Republic of China ("PRC"), today reported that it had added five new prescription drugs to its products delivered through its national sales channels.

3 Mar 2010

Exercising during weight regain can help improve metabolic health and disease risk

With the obesity rate rising for American adults and children, health concerns such as diabetes and cardiovascular disease are a frequent reality. Although obesity itself is a major risk factor for disease, most of the threat may be associated with a cluster of risk factors called the metabolic syndrome (MetS). Losing weight can improve health and reduce these risk factors, but many people have difficulty keeping the weight off.

3 Mar 2010

Novo Nordisk awarded contract by VA as primary source provider of insulin

Novo Nordisk, a global healthcare company and leader in diabetes care, announced it has been awarded a contract by the U.S. Department of Veterans Affairs as the primary source provider of insulin. The one year contract began on March 1, 2010 and the VA has the option to renew the contract annually for up to an additional four years.

From Novo Nordisk 3 Mar 2010

Diabetes News and Research

Latest Diabetes News and Research

Study on role of recorded ODLs in improving clinical care for low-weight babies: RWJF awards $480,000 grant

Belatacept drug can prevent graft rejection in kidney transplant recipients

Study suggests vitamin D supplements may decrease insulin resistance, fight depression

Study indicates ocular shingles may increase stroke risk

HHS Secretary asks Olympic athletes to combat the challenge of childhood obesity

CPEX Pharmaceuticals' fourth-quarter 2009 revenues up 23%

VUCCC files for patent protection: New treatment regimen for Type 1 insulin-dependent diabetes

Positive clinical trial results of EndoBarrier Gastrointestinal Liner device announced

"Stem cells in drug discovery and development" workshop to be held during toxicology annual meeting

Merck’s MF/F Phase III study data presented at AAAAI annual meeting

Merck announces updated late-stage pipeline following its recent merger with Schering-Plough

Diabetics at risk: Nova Scotia limits pharmacare coverage of blood glucose test strips

Instacare announces filing of patent application for MD@Hand technologies

Common diabetes therapies may increase cancer risk, but more research needed

Astellas commences unsolicited tender offer to acquire common shares of OSI for $52.00 per share

Junk food consumption on the rise among U. S. children

Nemours: New efforts to reduce prevalence of overweight and obesity among Delaware's children

Lotus Pharmaceuticals adds five new prescription drugs to its products

Exercising during weight regain can help improve metabolic health and disease risk

Novo Nordisk awarded contract by VA as primary source provider of insulin

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Diabetes News and Research

Latest Diabetes News and Research

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Newsletters you may be interested in